Circle November 6 - Huge Tesla News?

Tesla could be about to change forever. On November 6, insiders are warning of a "critical inflection point", which could have a dramatic impact on the stock market. Do not buy OR sell Tesla stock until you have all the facts.

Tesla Stock Is 'Mooning'—Thank Elon? (CORRECTED)

Erica Kollmann
October 03, 2025

Editor's Note: This article has been updated to correct the stock price figures.

Tesla, Inc. (NASDAQ:TSLA) stock has surged into October, following a tough first half of 2025 for the EV maker, during which shares slumped steeply while CEO Elon Musk spent time working with the Trump administration. 

  • TSLA stock is up 100% over the past month. See the details here. 

Musk Returns

Analysts and investors alike blamed Musk's political involvement for the drop, even as Wall Street revised price targets downward due to concerns over sluggish vehicle sales and increased competition.

Read Next: Tesla, Rivals Brace For EV Market ‘Collapse’--Thanks To Trump

However, sentiment turned sharply positive after Musk left D.C. and refocused on Tesla's core business. 

The social media account Whole Mars Catalog asked if investors should be thanking the CEO for the stock’s recent stellar performance since they blamed him for its drop. 

"You ever notice how whenever $TSLA is falling everyone blames Elon, but when it's mooning very few people thank him?" the account posted on X. 

Musk replied with a tearful laughing emoji and a bullseye emoji. 

TSLA Moons

Musk returned to a hands-on leadership role at Tesla in late May 2025, following his exit from heading the Department of Government Efficiency (DOGE). 

The CEO officially ended his work with DOGE and announced his renewed commitment to spending "24/7" at Tesla in a post on X on May 24, 2025. 

Musk's return was met with a surge in Tesla stock, as shares climbed 22% in May, with investors responding positively to his decision to refocus on Tesla's operations and technology roadmap. 

His return to Tesla also coincided with announcements about critical new products, such as the rollout of robotaxis and increased autonomy efforts. 

Perhaps investors should thank Musk for leaving Washington. Since then, the stock climbed from $339.34 on May 23 to close at approximately $436 on Thursday, Oct. 2.

Read Next: 

  • Opendoor’s Buyer Perks Are A ‘Nothing Burger’ -- Business Model Still A Mystery, Says Hedge Funder

Image: Shutterstock

Popular

OpenAI now worth $500 billion, possibly making it the world's most valuable startup

OpenAI could now be the world's most valuable startup, ahead of Elon Musk's SpaceX and TikTok's parent company ByteDance, after a secondary stock sale designed to retain employees at the ChatGPT maker.

2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI

On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares o

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits

Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.

Ex-Trump Lawyer Raises Alarms: 'I Have Never Been As Concerned As To Whether Our System Can Withstand The Pressure'

Abbe Lowell, a lawyer who once represented President Donald Trump's family, has expressed grave concerns over the potential harm the current administration could cause to the country's institutions.

Elon's $1,000,000,000,000 Payday - Ad

Elon Musk just made his biggest insider purchase of Tesla stock ever. He's preparing for a "mind blowing" new launch that could see Tesla move away from electric cars... and into a new market. If his plan succeeds, this is the stock to own.

Federal judge tosses Trump's $15B defamation lawsuit against New York Times

TAMPA, Fla. (AP) — A federal judge in Florida on Friday tossed President Donald Trump’s against New York Times.

Gold Success Absent From Fund Allocation, Survey Shows

Gold is soaring to its second-best year in half a century, up over 43% as investors hedge against inflation and geopolitical risks.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood — Dumps Kratos Defense Amid Taiwan Drone Buzz

On Sept 17, 2025, Cathie Wood-led Ark Invest executed significant trades involving Bullish, Kratos Defense, Pony AI, and Robinhood. These reflect Ark's focus on emerging tech and defense sectors.

Jimmy Fallon Plans To 'Hit Both Sides Equally' In Political Coverage: How Kimmel's Suspension Changed Things

Jimmy Fallon says he's mostly avoiding political jokes. This decision could keep him out of controversy and keep fans watching some of the biggest musical acts in October.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Bank of England holds main UK interest rate at 4% with inflation above target

LONDON (AP) — The Bank of England held its main interest rate at 4% on Thursday as U.K. inflation concerns weigh on policymakers.

Lam Research And JSR Resolve Legal Disputes As They Team Up On AI Era Chips

Lam Research and JSR Corp agreed to collaborate and cross-license, combining their expertise to accelerate semiconductor manufacturing and reduce costs.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Trump Poised To Delay TikTok Deadline Again Amid US–China Tension: 'We May Let It Die'

President Donald Trump is expected to extend the TikTok divestment deadline for a fourth time as ByteDance, valued at $330 billion with surging revenue, faces U.S.–China tensions over its prized algorithm.

Elon Musk's xAI Reportedly Lays Off 500 Workers From Data Annotation Team As Startup Pivots To Specialist AI Tutors For Grok Expansion

Elon Musk's xAI has laid off about 500 data annotators in a major restructuring, shifting focus to specialist AI tutors to accelerate Grok's development despite recently securing $10 billion in new funding.

Elon Musk Says November 6 Could "Affect the Future of the World" - Ad

Get ready for the biggest pivot in corporate history. Tesla insiders are preparing for a dramatic new product launch - not driverless cars - that could change everything. You're running out of time to prepare.

Scott Bessent Meets BlackRock's Rick Rieder As Trump Eyes Fed Chair Replacement For Jerome Powell: Report

Scott Bessent is interviewing candidates to replace Jerome Powell as Federal Reserve Chair by May 2026, with BlackRock's Rick Rieder among those being considered.

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership

Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

Long-wrought WTO agreement aimed at reducing overfishing takes effect

GENEVA (AP) — A World Trade Organization agreement aimed at reducing took effect Monday, requiring countries to reduce subsidies doled out to fishing fleets and aiming to ensure sustainability of wildlife in the world's seas and oceans.

Circle November 6 - Huge Tesla News? - Ad

Tesla could be about to change forever. On November 6, insiders are warning of a "critical inflection point", which could have a dramatic impact on the stock market. Do not buy OR sell Tesla stock until you have all the facts.

AI Bull Market Fuels A Wave Of New Listings: 3 IPO ETFs In Focus

IPO-ETFs like IPO, FPX and FPXI are in focus as the U.S. market sees its fastest rebound since 2021, fueled by the AI boom and $23B raised year-to-date.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

UN report cites huge government corruption in South Sudan as its food crisis worsens

NAIROBI, Kenya (AP) — Billions of dollars in public funds in South Sudan have been stolen over the past decade in massive government corruption while the vast majority of the country suffers food insecurity, a U.N. commission said Tuesday.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Big Tech's energy-hungry data centers could be bumped off grids during power emergencies

HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.

Labor Dispute Eases As UAW, GE Aerospace Agree On Tentative Pact

UAW members at GE Aerospace plants in Ohio and Kentucky reached a tentative deal, with a ratification vote set for Sept. 19.

Elon's $1,000,000,000,000 Payday - Ad

Elon Musk just made his biggest insider purchase of Tesla stock ever. He's preparing for a "mind blowing" new launch that could see Tesla move away from electric cars... and into a new market. If his plan succeeds, this is the stock to own.

Why Rivian Automotive Stock Is Gaining Today?

Rivian stock climbs after breaking ground on a multibillion-dollar Georgia EV plant.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service